Tenaya Therapeutics
TNYA
95 hedge funds and large institutions have $111M invested in Tenaya Therapeutics in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 17 closing their positions.
2,000% more call options, than puts
Call options by funds: $21K | Put options by funds: $1K
111% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 18
0.36% more ownership
Funds ownership: 72.69% → 73.05% (+0.36%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
1% less funds holding
Funds holding: 96 → 95 (-1)
37% less capital invested
Capital invested by funds: $177M → $111M (-$65.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.58M |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$1.55M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$639K |
| 4 |
Renaissance Technologies
New York
|
+$630K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$542K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.91M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$1.81M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.37M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$689K |
| 5 |
BC
BIT Capital
Berlin,
Germany
|
-$622K |
TNYA Hedge Fund Activity: Q3 2024 in Review
95 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q3 2024, worth a combined $111M — down 37% from $177M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of TNYA and 16 opened new positions — a net loss of 1 holder — while 18 trimmed existing stakes and 38 added.
The largest buyer was Schonfeld Strategic Advisors, adding an estimated $1.58M. The largest seller was Adage Capital Partners, cutting an estimated $1.91M.
- 95 institutional investors held Tenaya Therapeutics (TNYA) as of Q3 2024, down from 96 in Q2 2024.
- Funds reported $111M of Tenaya Therapeutics stock for Q3 2024, down 37% quarter-over-quarter.
- 16 funds opened new Tenaya Therapeutics positions in Q3 2024 and 17 closed out, a net change of -1 holder.
- The largest Tenaya Therapeutics buyer in Q3 2024 was Schonfeld Strategic Advisors, an estimated $1.58M added.
- The largest Tenaya Therapeutics seller in Q3 2024 was Adage Capital Partners, an estimated $1.91M sold.
Based on aggregated 13F filings for Q3 2024.